NCT04983966View on ClinicalTrials.gov

Comparison of Postoperative QoR-15 Scores Between Desflurane and Remimazolam in Lumbar Fusion Surgery

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 4, 2021

Primary Completion Date

February 14, 2024

Study Completion Date

February 14, 2024

Conditions
Lumbar Fusion Surgery
Interventions
DRUG

Desflurane

"General anesthesia for patients will be inducted and maintained with desflurane inhalation and remifentanil infusion.~Remimazolam group will be started with remiamazolam at 6 mg/kg/h and TCI Minto model of remifentanil for the time of anesthesia induction, and maintained at 0.5"

DRUG

Remimazolam

"General anesthesia for patients will be inducted and maintained with desflurane inhalation and remifentanil infusion.~Remimazolam group will be started with remiamazolam at 6 mg/kg/h and TCI Minto model of remifentanil for the time of anesthesia induction, and maintained at 0.5"

Trial Locations (1)

Unknown

GangnamSeverance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT04983966 - Comparison of Postoperative QoR-15 Scores Between Desflurane and Remimazolam in Lumbar Fusion Surgery | Biotech Hunter | Biotech Hunter